
Global Blood Therapeutics GBT
Quartalsbericht 2022-Q2
hinzugefügt 08.08.2022
Global Blood Therapeutics ROCE 2011-2026 | GBT
ROCE Jährlich Global Blood Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -146.47 | -37.86 | -39.96 | -31.3 | -36.08 | -44.48 | -32.59 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -31.3 | -146.47 | -52.68 |
ROCE Vierteljährlich Global Blood Therapeutics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -182.63 | -140.48 | -162.31 | -119.25 | -62.4 | -76.67 | -68.85 | -60.43 | -58.43 | -61.31 | -59.18 | -57.18 | -48.61 | -40.55 | -36.62 | -33.53 | -31.9 | -35.96 | -37.17 | -37.42 | -37.4 | -39.0 | -41.19 | -43.09 | -44.62 | -40.96 | -40.1 | -36.65 | -32.95 | -11.1 | 9.94 | 26.44 | 31.71 | 20.94 | 10.4 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 31.71 | -182.63 | -47.96 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
AbCellera Biologics
ABCL
|
-16.8 | $ 3.52 | -1.26 % | $ 1.05 B | ||
|
MorphoSys AG
MOR
|
2.89 | - | 2.43 % | $ 254 M | ||
|
Acorda Therapeutics
ACOR
|
167.74 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-25.04 | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
429.74 | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
-27.26 | $ 3.26 | 3.99 % | $ 229 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-29.3 | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
-180.78 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-325.06 | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
-119.71 | - | 10.36 % | $ 9.8 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | ||
|
ADC Therapeutics SA
ADCT
|
-48.11 | $ 4.13 | -1.67 % | $ 105 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
-35.64 | $ 6.39 | -3.62 % | $ 175 M | ||
|
argenx SE
ARGX
|
-211.69 | $ 705.24 | 0.28 % | $ 25 B | ||
|
Midatech Pharma plc
MTP
|
-337.43 | - | -18.52 % | $ 27.3 M | ||
|
Adverum Biotechnologies
ADVM
|
-196.79 | - | - | $ 86.2 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-104.38 | $ 3.45 | -4.43 % | $ 8.3 B | ||
|
Ascendis Pharma A/S
ASND
|
-45.89 | $ 229.27 | -0.76 % | $ 5 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-60.13 | - | - | $ 26.5 M | ||
|
Applied Molecular Transport
AMTI
|
-209.11 | - | - | $ 10.1 M | ||
|
Atea Pharmaceuticals
AVIR
|
-65.67 | $ 6.07 | 0.33 % | $ 495 M | ||
|
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - | ||
|
Akero Therapeutics
AKRO
|
-38.05 | - | - | $ 3.67 B | ||
|
Athersys
ATHX
|
-531.85 | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
-37.16 | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
146.85 | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
-23.06 | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
-252.54 | - | 3.16 % | $ 1.9 M | ||
|
Aeterna Zentaris
AEZS
|
-29.95 | - | 5.93 % | $ 314 M | ||
|
AlloVir
ALVR
|
-57.76 | - | 4.14 % | $ 49.1 M | ||
|
BioCardia
BCDA
|
726.39 | $ 1.29 | 1.57 % | $ 27.3 M | ||
|
Anika Therapeutics
ANIK
|
-41.29 | $ 14.45 | 0.63 % | $ 212 M | ||
|
Aptinyx
APTX
|
-163.42 | - | -39.0 % | $ 4.57 M | ||
|
Aptose Biosciences
APTO
|
-46.69 | - | -45.71 % | $ 1.2 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-108.03 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3412.47 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-12.81 | $ 2.59 | -2.08 % | $ 16.3 M | ||
|
Avenue Therapeutics
ATXI
|
-403.4 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
-161.2 | $ 1.5 | -0.99 % | $ 383 M | ||
|
Athira Pharma
ATHA
|
-225.02 | - | - | $ 269 M | ||
|
BioNTech SE
BNTX
|
-4.81 | $ 94.98 | 4.9 % | $ 27.2 B | ||
|
CureVac N.V.
CVAC
|
-51.5 | - | - | $ 867 M | ||
|
Burford Capital Limited
BUR
|
14.24 | $ 8.31 | 3.04 % | $ 1.34 B | ||
|
Aravive
ARAV
|
-664.7 | - | -13.39 % | $ 1.45 M | ||
|
AstraZeneca PLC
AZN
|
11.12 | - | - | $ 96.9 B | ||
|
Actinium Pharmaceuticals
ATNM
|
-128.58 | $ 1.15 | 3.6 % | $ 34.6 M |